AEE
61
3
GD
60
3
VRTX
55
2
DRI
48
3
UPS
48
5
JPM
69
3
ADM
30
2
CNX
56
4
PWR
67
5
ESS
57
6
NEM
44
3
T
51
6
BA
56
3
MO
38
2
MDLZ
38
2
XYL
62
4
DG
6
4
TMO
52
-2
CCI
30
2
BAX
44
-3
AEE
61
3
GD
60
3
VRTX
55
2
DRI
48
3
UPS
48
5
JPM
69
3
ADM
30
2
CNX
56
4
PWR
67
5
ESS
57
6
NEM
44
3
T
51
6
BA
56
3
MO
38
2
MDLZ
38
2
XYL
62
4
DG
6
4
TMO
52
-2
CCI
30
2
BAX
44
-3
Financhill
Back

Direxion Dly S&P Oil&Gs Ex&Prd Bl 2X ETF Vs. Kymera Therapeutics Industry Stock Comparison

Sell
34

GUSH
Direxion Dly S&P Oil&Gs Ex&Prd Bl 2X ETF

Last Price:
29.80
Seasonality Move:
6.54%
Buy
71

KYMR
Kymera Therapeutics

Last Price:
46.27
Seasonality Move:
65.72%
Sell
34
Direxion Dly S&P Oil&Gs Ex&Prd Bl 2X ETF (GUSH) is a Sell

Is Direxion Dly S&P Oil&Gs Ex&Prd Bl 2X ETF a Buy, Sell or Hold?

  • The current Direxion Dly S&P Oil&Gs Ex&Prd Bl 2X ETF [GUSH] share price is $29.28. The Score for GUSH is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • GUSH is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
71
Kymera Therapeutics (KYMR) is a Buy

Is Kymera Therapeutics a Buy, Sell or Hold?

  • The current Kymera Therapeutics [KYMR] share price is $49.02. The Score for KYMR is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
  • KYMR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

GUSH Stock Price Chart

What is Direxion Dly S&P Oil&Gs Ex&Prd Bl 2X ETF's stock price today?

  • The Direxion Dly S&P Oil&Gs Ex&Prd Bl 2X ETF share price today is $29.28
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GUSH is experiencing slight buying pressure.

KYMR Stock Price Chart

What is Kymera Therapeutics's stock price today?

  • The Kymera Therapeutics share price today is $49.02
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing buying pressure, which is a positive indicator for future bullish movement.

GUSH Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.26 Buy
Relative Strength Index (14 RSI): 46.67 Sell
Chaikin Money Flow: 62126 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (27.73 - 31.25) Sell
Bollinger Bands (100): (29.21 - 35.81) Sell

KYMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.28 Sell
Relative Strength Index (14 RSI): 59.12 Buy
Chaikin Money Flow: 317205 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (43.81 - 49.49) Buy
Bollinger Bands (100): (34.86 - 47.92) Buy

GUSH Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 30.87 Sell
20-day SMA: 29.98 Sell
50-day SMA: 29.84 Sell
200-day SMA: 34.23 Sell
8-day EMA: 30.32 Sell
20-day EMA: 30.09 Sell
50-day EMA: 30.51 Sell
200-day EMA: 33.4 Sell

KYMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 44.58 Buy
20-day SMA: 46.67 Buy
50-day SMA: 46.11 Buy
200-day SMA: 38.62 Buy
8-day EMA: 45.67 Buy
20-day EMA: 45.85 Buy
50-day EMA: 45.2 Buy
200-day EMA: 38.5 Buy

Direxion Dly S&P Oil&Gs Ex&Prd Bl 2X ETF Earnings Growth & GUSH Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Kymera Therapeutics Earnings Growth & KYMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and a decrease next year of $0.47 per share.

Direxion Dly S&P Oil&Gs Ex&Prd Bl 2X ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kymera Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):